StockData
Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc. (GLSI) income statement

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 6/30
$20.58+1.88 (+10.05%)

Close on Nov 18, 2026Market cap $302.08MP/E –Yield –

Greenwich LifeSciences, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-3068.2%

Financial strength

Current ratio
1.54
Debt to equity
–
Debt to assets
–
Cash to current liabilities
154.1%

Valuation

P/E ratio
–
Price to sales
–
Price to book
96.91
Dividend yield
–

See a number that looks wrong?